• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位肝移植术后接受他克莫司(FK506)治疗的儿童出现明显左心室肥厚。

Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation.

作者信息

Chang R K, Alzona M, Alejos J, Jue K, McDiarmid S V

机构信息

Department of Pediatrics, UCLA Medical Center, Los Angeles, California 90024, USA.

出版信息

Am J Cardiol. 1998 May 15;81(10):1277-80. doi: 10.1016/s0002-9149(98)00126-x.

DOI:10.1016/s0002-9149(98)00126-x
PMID:9604971
Abstract

Although the cardiac effects of tacrolimus (FK506) have not been well documented, clinical cases of children on FK506 who developed hypertrophic obstructive cardiomyopathy have been reported. We report 2 cases of marked concentric hypertrophy of the left ventricular myocardium found at autospy in children on FK506.

摘要

尽管他克莫司(FK506)对心脏的影响尚未有充分记录,但已有报告称使用FK506的儿童出现肥厚性梗阻性心肌病的临床病例。我们报告了2例在尸检中发现使用FK506的儿童左心室心肌出现明显同心性肥厚的病例。

相似文献

1
Marked left ventricular hypertrophy in children on tacrolimus (FK506) after orthotopic liver transplantation.原位肝移植术后接受他克莫司(FK506)治疗的儿童出现明显左心室肥厚。
Am J Cardiol. 1998 May 15;81(10):1277-80. doi: 10.1016/s0002-9149(98)00126-x.
2
Tacrolimus-induced left ventricular apical hypertrophy in a patient with post-allogeneic hematopoietic stem cell transplantation.他克莫司诱导的异基因造血干细胞移植患者左心室心尖肥厚
Int J Cardiol. 2014 Nov 15;177(1):e22-4. doi: 10.1016/j.ijcard.2014.07.171. Epub 2014 Aug 4.
3
Asymmetric cardiac hypertrophy at autopsy in patients who received FK506 (tacrolimus) or cyclosporine A after liver transplant.肝移植后接受FK506(他克莫司)或环孢素A治疗的患者尸检时出现不对称性心脏肥大。
Transplantation. 2002 Sep 27;74(6):817-21. doi: 10.1097/00007890-200209270-00015.
4
[Cardiac hypertrophy in kidney transplanted female patient treated with tacrolimus].[接受他克莫司治疗的肾移植女性患者的心脏肥大]
Med Clin (Barc). 2002 Nov 23;119(18):715. doi: 10.1016/s0025-7753(02)73548-3.
5
Echocardiographic findings of hypertrophic cardiomyopathy in children after orthotopic liver transplantation.原位肝移植术后儿童肥厚型心肌病的超声心动图表现
Pediatr Transplant. 2001 Jun;5(3):187-91. doi: 10.1034/j.1399-3046.2001.00052.x.
6
Tacrolimus and myocardial hypertrophy.他克莫司与心肌肥大。
Transplantation. 2000 May 15;69(9):1960-2. doi: 10.1097/00007890-200005150-00039.
7
Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient.成人心脏移植患者中环孢素相关肥厚型心肌病。
Chin Med J (Engl). 2012 Apr;125(7):1352-4.
8
Administration of tacrolimus in 50 liver transplantation patients.50例肝移植患者使用他克莫司的情况。
Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):492-4.
9
Cardiac hypertrophy postliver transplantation: a role for FK506 and cyclosporine A?肝移植后心脏肥大:FK506和环孢素A的作用?
Transplantation. 2002 Sep 27;74(6):757-8. doi: 10.1097/00007890-200209270-00004.
10
[Mesial temporal lobe epilepsy in a patient with Wilson's disease receiving FK506 (tacrolimus) after liver transplantation].肝移植后接受FK506(他克莫司)治疗的威尔逊病患者的内侧颞叶癫痫
No To Hattatsu. 2001 Jul;33(4):342-6.

引用本文的文献

1
Left Ventricular Hypertrophy and Hypertrophic Cardiomyopathy in Adult Solid Organ Transplant Recipients.成年实体器官移植受者的左心室肥厚与肥厚型心肌病
Transplant Direct. 2021 Dec 13;8(1):e1279. doi: 10.1097/TXD.0000000000001279. eCollection 2022 Jan.
2
Reverse ventricular remodeling and improved ventricular compliance after heart transplantation in infants and young children.婴幼儿心脏移植后心室逆向重构及心室顺应性改善。
Pediatr Cardiol. 2014 Aug;35(6):922-7. doi: 10.1007/s00246-014-0876-8. Epub 2014 Feb 9.
3
Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.
小儿肝移植受者从环孢素转换为他克莫司。
Paediatr Drugs. 2001;3(9):661-72. doi: 10.2165/00128072-200103090-00004.
4
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司:其在器官移植管理中的药理学及治疗应用的进一步更新
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.